女性的血病状况和胚胎载体状况不会影响经过euploid转移后的妊娠结果
Li Fan1,2, Zhetao Li1,2, Wugao Li1,2
1Department of Reproductive Medicine, Guangzhou Women and Children's Medical Center Liuzhou Hospital, Liuzhou, Guangxi, China.
Frontiers in endocrinology
|November 7, 2025
概括
在试管婴儿期间输卵性胚胎转移后,血病携带者身份和胚胎基因型不会影响妊娠结果. 这支持将血病载体胚胎和个性化生殖策略转移给与PGT进行试管婴儿的夫妇.
科学领域:
- 生殖医学 生殖医学
- 遗传学 是一个遗传学.
- 产科 产科 产科 产科 产科
背景情况:
- 单一性疾病的植入前遗传测试 (PGT-M) 用于预防严重的血病.
- 有限的数据存在于血病携带者身份或胚胎基因型对PGT-A期间怀孕结果的影响.
研究的目的:
- 调查血病状况和胚胎基因型对通过PGT-A进行试管婴儿的妇女怀孕结果的影响.
- 评估临床怀孕,活产和流产率与血病相关的情况.
主要方法:
- 对981名女性进行了回顾性队列研究,这些妇女接受了首次自主试管婴儿与单个胚胎移植的试管婴儿.
- 512名患有沙拉西米亚的妇女与460名对照妇女进行了比较,所有妇女都接受了PGT-A.
- 根据年龄,BMI和子宫内膜厚度进行调整的Poisson回归模型.
主要成果:
- 在临床怀孕,活产或脱胎率中没有显著的差异,在thalassemia患者和对照人群之间.
- 没有观察到具有或没有致病性血病变体的胚胎之间存在显著差异.
- 在thalassemia状态和临床变量之间没有发现协同效应.
结论:
- thalassemia状态和胚胎基因型不会对euploid胚胎移植后的怀孕结果产生不利影响.
- 支持转移异合体血病载体胚胎.
- 能够为具有遗传风险的夫妇提供个性化生殖咨询和胚胎选择.
更多相关视频
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.8K
05:36Author Spotlight: Inducing Pseudopregnancy in Female Mice Without the Need for Vasectomized Males Prior to Non-Surgical Embryo Transfer or Artificial Insemination
Published on: July 7, 2023
9.7K
相关概念视频
Meiosis vs. Mitosis
69.2K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
69.2K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Oogenesis
68.9K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.9K
Meiosis II
206.6K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
206.6K
Infertility in Females
3.6K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.6K
Nondisjunction
4.8K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.8K
